You just read:

Innovent Provides Update on Phase Ib Study of Sintilimab in Combination with Chemotherapy for First-line Advanced or Metastatic Non-small Cell Lung Cancer

News provided by

Innovent Biologics, Inc.

May 30, 2019, 20:00 ET